New patent expiration for United Therap drug ORENITRAM
Drug Patent Watch
JULY 13, 2024
Annual Drug Patent Expirations for ORENITRAM Orenitram is a drug marketed by United Therap and is included in one NDA. It is available from one supplier.
Drug Patent Watch
JULY 13, 2024
Annual Drug Patent Expirations for ORENITRAM Orenitram is a drug marketed by United Therap and is included in one NDA. It is available from one supplier.
Drugs.com
JULY 13, 2024
SATURDAY, July 13, 2024 -- The human body is no match for extreme heat, and scorching temperatures seem to be the rule rather than the exception these days."It's hard to think of an organ that is not affected by the heat," said Craig Crandall.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Patent Watch
JULY 13, 2024
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.
Drug Patent Watch
JULY 13, 2024
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Ireland.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Let's personalize your content